Intermediate Capital Group plc Announces Realis...

REG - Intermediate Capital - Realisation

25 October 2013

Intermediate Capital Group plc announces realisation

Further to prior announcements of realisations, Intermediate Capital Group plc ("ICG") announces that the mezzanine investments made by ICG and members of its group and the ICG European Fund 2006 (the "Fund") in Ethypharm have been realised. The original investments were €55m; total proceeds received at the time of exit were €86.05m, with 60% of the proceeds being received by ICG and the remainder received by the Fund. In addition, Ethypharm has partially repaid its convertible bonds. Total proceeds received as a result of this bond repayment amounted to €5.4m, with 60% of the proceeds being received by ICG and the remainder received by the Fund. ICG continues to hold convertible bonds and an equity stake following the realisation. Ethypharm is the leading European player in the development and manufacturing of specific value-added drug delivery systems

ICG will continue to make the market aware of significant realisations.

Investor Enquiries: 
Ian Stanlake
Investor Relations, ICG plc
[phone]

Media Enquiries:

Helen Barnes
Corporate Communications, ICG plc
[phone]

Neil Bennett
Maitland
[phone]

---

This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients.

The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and other applicable laws; and
(ii) they are solely responsible for the content, accuracy and originality of the
information contained therein.

Source: Intermediate Capital Group plc via Thomson Reuters ONE

HUG#1738218